 |
 |
 |
 |
 |
 |
|
||||||||||||||
Select Publications
Albain K et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-positive, ER-positive breast cancer (S8814, INT0100). San Antonio Breast Cancer Symposium 2007;Abstract 10.
The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists’ Group. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100- month analysis of the ATAC trial. Lancet Oncol 2008;9(1):45-53. Abstract
Bear HD et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24(13):2019-27.
Abstract
Fisher B et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;90(18):1371-88. Abstract
Mamounas EP et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol B- 27. J Clin Oncol 2005;23(12):2694-702. Abstract
Morrow M, Jordon VC. The current status of breast cancer chemoprevention: A star is born. J Surg Oncol 2007;95(1):4-5. Abstract
Rastogi P et al. Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008;26(5):778-85. Abstract
Vogel VG et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295(23):2727-41. Abstract
| Table of Contents | Top of Page |
INTERVIEWS
Neil Love, MD
Editor
Monica Morrow, MD
- Select publications
Ian E Smith, MD
- Select publications
Robert W Carlson, MD
- Select publications
Soonmyung Paik, MD
- Select publications
Breast Cancer Update
for Surgeons:
A CME Audio Series and Activity
 |
 |
 |
 |
 |
